| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.35 | 2e-10 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 7e-06 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 9e-06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 5e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.23 | 7e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |